Patent · US Active

Porphyrin compounds and their use as MRI contrast agents

US10646595B2 · kind B2 · utility

0Cited by
6References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 12, 2013
Grant dateMay 12, 2020
Priority date—
Expiry dateMar 6, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/106
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Water soluble porphyrin compounds useful in the field of magnetic resonance imaging (MRI) as contrast agents. Particular compounds include manganese.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.